Matt Kalaycio
- Hematology top 0.1%
- Acute Myeloid Leukemia Research 119
- Hematopoietic Stem Cell Transplantation 64
- Chronic Myeloid Leukemia Treatments 59
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 61
- Myeloproliferative Neoplasms: Diagnosis and Treatment 46
- Transplantation top 2%
- Oncology top 2%
- Neutropenia and Cancer Infections 23
-
- Lymphoma Diagnosis and Treatment 50
-
- Acute Lymphoblastic Leukemia research 70
- Co-authors
- Mikkael A. SekeresRonald SobecksHagop M. KantarjianLisa RybickiAnjali S. AdvaniBrian J. BolwellJaroslaw P. MaciejewskiEdward A. Copelan
- Cited by
- HematologyGeneticsTransplantation
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Matt Kalaycio
282 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Hematology 3.3k
- Genetics 1.5k
- Transplantation 146
- Oncology 1.2k
- Pathology and Forensic Medicine 642
Countries citing papers authored by Matt Kalaycio
This map shows the geographic impact of Matt Kalaycio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matt Kalaycio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matt Kalaycio more than expected).
Fields of papers citing papers by Matt Kalaycio
This network shows the impact of papers produced by Matt Kalaycio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matt Kalaycio. The network helps show where Matt Kalaycio may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matt Kalaycio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 2 | |
| 7 | 2021 | 1 | |
| 8 | 2021 | 4 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 5 | |
| 11 | 2019 | 1 | |
| 12 | 2019 | 7 | |
| 13 | 2019 | 1 | |
| 14 | 2017 | 6 | |
| 15 | 2017 | 1 | |
| 16 | 2017 | 5 | |
| 17 | 2017 | 1 | |
| 18 | 2013 | 3 | |
| 19 | 2010 | 2 | |
| 20 | 2008 | 146 |
About Matt Kalaycio
Matt Kalaycio is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 291 papers that have together received 5.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (119 papers), Acute Lymphoblastic Leukemia research (70 papers), Hematopoietic Stem Cell Transplantation (64 papers), Chronic Lymphocytic Leukemia Research (61 papers), Chronic Myeloid Leukemia Treatments (59 papers), Lymphoma Diagnosis and Treatment (50 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (46 papers) and Neutropenia and Cancer Infections (23 papers). The work is most often cited by research in Hematology (3.3k citations), Genetics (1.5k citations) and Transplantation (146 citations). Matt Kalaycio has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Mikkael A. Sekeres, Ronald Sobecks, Hagop M. Kantarjian, Lisa Rybicki, Anjali S. Advani, Brian J. Bolwell, Jaroslaw P. Maciejewski, Edward A. Copelan, Brad Pohlman and David A. Scheinberg. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.